2,268
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis

, , , , &
Pages 5583-5594 | Received 04 Jun 2021, Accepted 24 Jul 2021, Published online: 13 Sep 2021

References

  • Zhang X-J, Cui Z-H, Zhao Y-X, et al. Ferulic acid ameliorates isoproterenol-induced heart failure by decreasing oxidative stress and inhibiting cardiocyte apoptosis via activating Nrf2 signaling pathway in rats. Biol Pharm Bull. 2021;44(3):396–403.
  • Cheng H, Wu X, Ni G, et al. Citri reticulatae pericarpium protects against isoproterenol-induced chronic heart failure via activation of PPARγ. Ann Transl Med. 2020;8(21):1396.
  • McNair BD, Schlatter JA, Cook RF, et al. Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice. Exp Gerontol. 2021;151:111395.
  • Yu X, Chen X, Amrute-Nayak M, et al. MARK4 controls ischaemic heart failure through microtubule detyrosination. Nature. 2021;594:560–565.
  • Hu H, Fu Y, Li M, et al. Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactions. Int Immunopharmacol. 2020;86:106725.
  • Yao J, Li Y, Jin Y, et al. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways. Int Immunopharmacol. 2021;96:107728.
  • Cook C, Cole G, Asaria P, et al. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–376.
  • Park JB. Synthesis and characterization of norbelladine, a precursor of Amaryllidaceae alkaloid, as an anti-inflammatory/anti-COX compound. Bioorg Med Chem Lett. 2014;24(23):5381–5384.
  • Mester-Tonczar J, Winkler J, Einzinger P, et al. Association between circular RNA CDR1as and post-infarction cardiac function in pig ischemic heart failure: influence of the anti-fibrotic natural compounds bufalin and lycorine. Biomolecules. 2020;10(8):1180.
  • Yang Y-J, Liu J-N, Pan X-D. Synthesis and antiviral activity of lycorine derivatives. J Asian Nat Prod Res. 2020;22(12):1188–1196.
  • Zhang W, Yang J, Chen Y, et al. Lycorine hydrochloride suppresses stress-induced premature cellular senescence by stabilizing the genome of human cells. Aging Cell. 2021;20(2):e13307.
  • Cao Z, Yang P, Zhou Q. Multiple biological functions and pharmacological effects of lycorine. Sci China Chem. 2013;56(10):1382–1391.
  • Zhang P, Yuan X, Yu T, et al. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts in vitro cytostatic effects in human colorectal cancer via activating the ROS/p38 and AKT signaling pathways. Oncol Rep. 2021;45(4):19.
  • Li C, Deng C, Pan G, et al. Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer. J Exp Clin Cancer Res. 2020;39(1):230.
  • Wang C, Wang Q, Li X, et al. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade. Biochem Biophys Res Commun. 2017;483(1):197–202.
  • Zhao Z, Xiang S, Qi J, et al. Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy. Cell Death Dis. 2020;11(5):387.
  • Shi S, Li C, Zhang Y, et al. Lycorine hydrochloride inhibits melanoma cell proliferation, migration and invasion via down-regulating p21 Cip1/WAF1. Am J Cancer Res. 2021;11(4):1391–1409.
  • Wang H, Gong Y, Liang L, et al. Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/β-catenin pathway. Br J Haematol. 2020;189(6):1151–1164.
  • Yuan X-H, Zhang P, Yu -T-T, et al. Lycorine inhibits tumor growth of human osteosarcoma cells by blocking Wnt/β-catenin, ERK1/2/MAPK and PI3K/AKT signaling pathway. Am J Transl Res. 2020;12(9):5381–5398.
  • Hu M, Yu Z, Mei P, et al. Lycorine Induces autophagy-associated apoptosis by targeting MEK2 and enhances vemurafenib activity in colorectal cancer. Aging (Albany NY). 2020;12(1):138–155.
  • Ying X, Huang A, Xing Y, et al. Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway. Sci China Life Sci. 2017;60(4):417–428.
  • Wang P, Li L-F, Wang Q-Y, et al. Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives. ChemMedChem. 2014;9(7):1522–1533.
  • Chen H, Lao Z, Xu J, et al. Antiviral activity of lycorine against Zika virus in vivo and in vitro. Virology. 2020;546:88–97.
  • Jin Y-H, Min JS, Jeon S, et al. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. Phytomedicine. 2021;86:153440.
  • Ge X, Meng X, Fei D, et al. Lycorine attenuates lipopolysaccharide-induced acute lung injury through the HMGB1/TLRs/NF-κB pathway. 3 Biotech. 2020;10(8):369.
  • Liang Q, Cai W, Zhao Y, et al. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. Pharmacol Res. 2020;158:104884.
  • Ahmed LA, Mohamed AF, Abd El-Haleim EA, et al. Boosting Akt pathway by rupatadine modulates Th17/Tregs balance for attenuation of isoproterenol-induced heart failure in rats. Front Pharmacol. 2021;12:651150.
  • Xu G-R, Zhang C, Yang H-X, et al. Modifified citrus pectin ameliorates myocardial fifibrosis and inflflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway. Biomed Pharmacother. 2020;126:110071.
  • Schimmel K, Jung M, Foinquinos A, et al. Natural compound library screening identifies new molecules for the treatment of cardiac fibrosis and diastolic dysfunction. Circulation. 2020;141(9):751–767.
  • Liu H, Zhang X, Shao Y, et al. Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway. Bioengineered. 2021;12(1):3113–3124.
  • Guo W, Guan X, Pan X, et al. Post-natal inhibition of NF-κB activation prevents renal damage caused by prenatal LPS exposure. PLoS One. 2016;11(4):e0153434.